Deemar Pharmaceuticals Private Limited
About Deemar Pharmaceuticals Private Limited
Data last updated:
Deemar Pharmaceuticals Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the social science research segment of the research and development sector. It was incorporated on 17 September 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U73200TG2021PTC155035.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Dokuri Mohan Reddy and Priyanka.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at H No 12 – 6 – 2/247 2nd Floor Vivek Nagar Kukatpally, Hyderabad, Telangana, India – 500072.
As per the financials filed for FY 2025, the company reported a revenue of ₹69.5 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹85,193 (net margin -1.2%) and EBITDA of -₹85,193 (EBITDA margin -1.2%).
Company details
Contact details
Deemar Pharmaceuticals Private Limited's registered office is in Hyderabad, Telangana.
- Registered AddressH No 12 – 6 – 2/247 2nd Floor Vivek Nagar Kukatpally, Hyderabad, Telangana, India – 500072
- IndustryResearch & Development, Social Science Research
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Deemar Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Deemar Pharmaceuticals Private Limited, buy the company report.
Financials of Deemar Pharmaceuticals Private Limited
FY 2025 filings availableDeemar Pharmaceuticals Private Limited reported revenue of ₹69.5 Lakh (up 46233% YoY) for FY 2025.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | -₹85,193 | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | -₹85,193 | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | -1.2% | |||
| Net Profit Margin | -1.2% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Deemar Pharmaceuticals Private Limited, buy the company report.
Board of directors of Deemar Pharmaceuticals Private Limited
Deemar Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Dokuri Mohan Reddy | Director | 17 Sep 2021 | 5 Years 1 Months | Current |
| Priyanka | Director | 17 Sep 2021 | 5 Years 1 Months | Current |
Peer comparison
Deemar Pharmaceuticals Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Hahnemann Pharmaceuticals Private Limited | ₹70.46 Lakh (FY 2024) | 28.0% | New Delhi, Delhi, India | |||
| Cross Berry Pharmaceuticals Private Limited | ₹69.6 Lakh (FY 2020) | 50.0% | Kolhapur, Maharashtra, India | |||
| Deemar Pharmaceuticals Private Limitedthis company | ₹69.5 Lakh (FY 2025) | -₹85,193 | -1.2% | 46233.0% | Hyderabad, Telangana, India | |
| Medcorpus Pharmaceuticals Private Limited | ₹69.28 Lakh (FY 2025) | 4.0% | Kolathur, Tamil Nadu, India |
To see the full peer comparison of Deemar Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Deemar Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Deemar Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Deemar Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Deemar Pharmaceuticals Private Limited has 2 board changes on record since 2021: 2 appointments. The latest: Dokuri Mohan Reddy was appointed as Director on 17 Sep 2021.
Frequently asked questions
Deemar Pharmaceuticals is an active private limited company based in Hyderabad, Telangana, India. The company works in social science research, within the research and development industry. It was incorporated on 17 September 2021 (5+ years old) and is registered under CIN U73200TG2021PTC155035.
Deemar Pharmaceuticals has 2 current directors:
- Dokuri Mohan Reddy - Director
- Priyanka - Director
The latest financial statements of Deemar Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.
The CIN (Corporate Identification Number) of Deemar Pharmaceuticals is U73200TG2021PTC155035. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Deemar Pharmaceuticals was incorporated on 17 September 2021, making it 5+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Deemar Pharmaceuticals by revenue are Hahnemann Pharmaceuticals Private Limited, Cross Berry Pharmaceuticals Private Limited, Medcorpus Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Dokuri Mohan Reddy was appointed as Director on 17 Sep 2021. Priyanka was appointed as Director on 17 Sep 2021.
The registered office of Deemar Pharmaceuticals is at H No 12 – 6 – 2247 2nd Floor Vivek Nagar Kukatpally, Hyderabad, Telangana, India – 500072.
Deemar Pharmaceuticals operates in the research and development industry, in the social science research segment.
Deemar Pharmaceuticals can be reached at its registered office: H No 12 – 6 – 2247 2nd Floor Vivek Nagar Kukatpally, Hyderabad, Telangana, India – 500072.
Deemar Pharmaceuticals is registered under the jurisdiction of the Registrar of Companies (ROC), Hyderabad.